Fate Therapeutics Growth Metrics (2012-2026) | FATE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	0.02M	0.00M	-0.02M	0.00M	-0.01M	-0.02M	0.03M	0.04M	-0.63M	-0.21M	-0.27M	-0.26M	0.60M	0.09M	-0.05M	0.01M	-0.13M	-0.03M	0.08M	-635.00
EBITDA Margin Growth (3y) (Quarter)	0.16M	0.12M	0.06M	0.04M	0.04M	0.05M	0.09M	0.13M	-0.62M	-0.22M	-0.27M	-0.22M	-0.03M	-0.13M	-0.29M	-0.21M	-0.15M	-0.14M	-0.24M	-0.25M
EBITDA Margin Growth (5y) (Quarter)	0.04M	0.04M	0.03M	0.06M	0.05M	0.04M	0.10M	0.13M	-0.48M	-0.10M	-0.19M	-0.19M	0.02M	-0.06M	-0.23M	-0.12M	-0.14M	-0.16M	-0.23M	-0.21M
EBITDA Margin (QoQ) (Quarter)	0.01M	-0.00M	-0.00M	208.00	-0.00M	-0.01M	0.04M	0.01M	-0.67M	0.41M	-0.02M	0.02M	0.20M	-0.10M	-0.16M	0.08M	0.06M	-0.01M	-0.05M	-418.00
EBIT Margin Growth (1y) (Quarter)	0.02M	0.00M	-0.02M	0.00M	-0.01M	-0.02M	0.03M	0.04M	-0.63M	-0.21M	-0.27M	-0.26M	0.60M	0.09M	-0.05M	0.01M	-0.13M	-0.03M	0.08M	-635.00
EBIT Margin Growth (3y) (Quarter)	0.16M	0.12M	0.06M	0.04M	0.04M	0.05M	0.09M	0.13M	-0.62M	-0.22M	-0.27M	-0.22M	-0.03M	-0.13M	-0.29M	-0.21M	-0.15M	-0.14M	-0.24M	-0.25M
EBIT Margin Growth (5y) (Quarter)	0.04M	0.04M	0.03M	0.06M	0.05M	0.04M	0.10M	0.13M	-0.48M	-0.10M	-0.19M	-0.19M	0.02M	-0.06M	-0.23M	-0.12M	-0.14M	-0.16M	-0.23M	-0.21M
EBIT Margin (QoQ) (Quarter)	0.01M	-0.00M	-0.00M	208.00	-0.00M	-0.01M	0.04M	0.01M	-0.67M	0.41M	-0.02M	0.02M	0.20M	-0.10M	-0.16M	0.08M	0.06M	-0.01M	-0.05M	-418.00
EBT Margin Growth (1y) (Quarter)	0.31M	0.13M	-0.06M	0.07M	-0.05M	0.07M	0.09M	0.03M	-1.16M	-0.99M	-2.11M	-0.53M	1.02M	0.45M	-0.06M	-0.49M	0.05M	0.22M	2.02M	-0.11M
EBT Margin Growth (3y) (Quarter)	0.10M	-0.01M	-0.08M	0.03M	-0.06M	0.01M	0.02M	0.90M	-0.90M	-0.80M	-2.08M	-0.43M	-0.19M	-0.48M	-2.08M	-0.98M	-0.09M	-0.33M	-0.16M	-1.12M
EBT Margin Growth (5y) (Quarter)	-0.01M	-0.08M	-0.10M	0.05M	-0.05M	-668.00	0.05M	0.12M	-1.12M	-0.93M	-2.10M	-0.47M	-0.21M	-0.54M	-2.16M	-0.12M	0.17M	-0.13M	-0.13M	-1.02M
EBT Margin (QoQ) (Quarter)	0.02M	-0.08M	-0.00M	0.12M	-0.10M	0.04M	0.02M	0.07M	-1.29M	0.21M	-1.10M	1.65M	0.25M	-0.36M	-1.61M	1.23M	0.79M	-0.20M	0.20M	-0.90M
Enterprise Value Growth (1y) (Quarter)	-30.41%	-38.85%	-27.54%	27.38%	18.22%	25.57%	29.17%	28.74%	33.56%	30.76%	27.75%	6.20%	19.33%	15.10%	11.46%	37.31%	26.91%	27.45%	27.02%	27.29%
Enterprise Value Growth (3y) (Quarter)	-107.36%	-47.57%	-45.25%	-46.35%	-51.99%	-18.60%	-25.36%	-26.23%	10.85%	10.56%	13.26%	21.41%	24.04%	24.09%	23.19%	25.17%	26.83%	24.73%	22.42%	24.67%
Enterprise Value Growth (5y) (Quarter)	-72.21%	-70.85%	-46.23%	-47.46%	-51.61%	-48.81%	-34.01%	-35.77%	-37.10%	-10.61%	-9.41%	-15.95%	-13.48%	0.39%	-4.74%	-3.41%	16.02%	15.11%	15.86%	26.04%
Enterprise Value (QoQ) (Quarter)	11.96%	2.43%	9.25%	6.84%	0.86%	11.20%	13.64%	6.26%	7.57%	7.46%	9.88%	-21.69%	20.51%	2.61%	6.01%	13.85%	7.32%	3.32%	5.46%	14.16%
FCF Margin Growth (1y) (Quarter)	-0.11M	0.03M	-0.05M	-0.01M	-0.00M	-0.03M	0.06M	0.03M	-0.29M	-0.13M	-0.24M	-0.17M	0.28M	0.07M	0.10M	-0.04M	-0.08M	-0.04M	-0.06M	-0.03M
FCF Margin Growth (3y) (Quarter)	0.08M	0.03M	0.00M	0.04M	0.04M	0.04M	0.09M	0.10M	-0.40M	-0.13M	-0.24M	-0.15M	-0.01M	-0.08M	-0.08M	-0.17M	-0.09M	-0.09M	-0.20M	-0.23M
FCF Margin Growth (5y) (Quarter)	0.04M	0.06M	0.01M	0.04M	0.05M	0.06M	0.10M	0.12M	-0.21M	-0.13M	-0.18M	-0.10M	0.03M	-0.01M	-0.05M	-0.10M	-0.20M	-0.09M	-0.20M	-0.21M
FCF Margin (QoQ) (Quarter)	-0.01M	0.02M	-0.06M	0.03M	-812.00	-0.00M	0.03M	0.01M	-0.32M	0.16M	-0.08M	0.08M	0.13M	-0.05M	-0.05M	-0.06M	0.08M	-0.01M	-0.07M	-0.03M
Interest Coverage Ratio Growth (1y) (Quarter)	-293.35%	-79.45%	-31.96%	-737.25%	22.51%	-319.74%	28.92%	90.70%	-118.62%	74.81%	31.76%	-106.19%	70.46%	-11.94%	-14.92%	64.40%	-1,068.80%	-133.64%		10.90%
Interest Coverage Ratio Growth (3y) (Quarter)	76.76%	80.44%	80.12%	55.02%	80.47%	73.78%	81.39%	-34.91%	-88.18%	-23.80%	13.82%	-17.11%	20.61%	-5.78%	17.70%	59.13%	-96.17%	12.99%		13.20%
Interest Coverage Ratio Growth (5y) (Quarter)	49.93%	57.49%	-14.98%	32.51%	60.24%	46.29%	51.85%	58.25%	53.71%	62.01%	67.17%	55.50%	65.61%	65.23%	65.27%	-12.50%	-87.23%	-37.76%		12.62%
Interest Coverage Ratio (QoQ) (Quarter)	-4.15%	49.68%	-5.05%	-1,420.82%	90.36%	-172.56%	82.21%	-99.03%	-126.54%	68.60%	51.80%	-501.36%	67.54%	-19.00%	50.52%	-86.30%	-965.57%	76.21%
Net Margin Growth (1y) (Quarter)	0.31M	0.13M	-0.06M	0.07M	-0.05M	0.07M	0.09M	0.03M	-1.16M	-0.99M	-2.11M	-0.53M	1.02M	0.45M	-0.06M	-0.49M	0.05M	0.22M	2.02M	-0.11M
Net Margin Growth (3y) (Quarter)	0.10M	-0.01M	-0.08M	0.03M	-0.06M	0.01M	0.02M	0.90M	-0.90M	-0.80M	-2.08M	-0.43M	-0.19M	-0.48M	-2.08M	-0.98M	-0.09M	-0.33M	-0.16M	-1.12M
Net Margin Growth (5y) (Quarter)	-0.01M	-0.08M	-0.10M	0.05M	-0.05M	-668.00	0.05M	0.12M	-1.12M	-0.93M	-2.10M	-0.47M	-0.21M	-0.54M	-2.16M	-0.12M	0.17M	-0.13M	-0.13M	-1.02M
Net Margin (QoQ) (Quarter)	0.02M	-0.08M	-0.00M	0.12M	-0.10M	0.04M	0.02M	0.07M	-1.29M	0.21M	-1.10M	1.65M	0.25M	-0.36M	-1.61M	1.23M	0.79M	-0.20M	0.20M	-0.90M
Operating Margin Growth (1y) (Quarter)	0.02M	0.00M	-0.02M	0.00M	-0.01M	-0.02M	0.03M	0.04M	-0.63M	-0.21M	-0.27M	-0.26M	0.60M	0.09M	-0.05M	0.01M	-0.13M	-0.03M	0.08M	-635.00
Operating Margin Growth (3y) (Quarter)	0.16M	0.12M	0.06M	0.04M	0.04M	0.05M	0.09M	0.13M	-0.62M	-0.22M	-0.27M	-0.22M	-0.03M	-0.13M	-0.29M	-0.21M	-0.15M	-0.14M	-0.24M	-0.25M
Operating Margin Growth (5y) (Quarter)	0.04M	0.04M	0.03M	0.06M	0.05M	0.04M	0.10M	0.13M	-0.48M	-0.10M	-0.19M	-0.19M	0.02M	-0.06M	-0.23M	-0.12M	-0.14M	-0.16M	-0.23M	-0.21M
Operating Margin (QoQ) (Quarter)	0.01M	-0.00M	-0.00M	208.00	-0.00M	-0.01M	0.04M	0.01M	-0.67M	0.41M	-0.02M	0.02M	0.20M	-0.10M	-0.16M	0.08M	0.06M	-0.01M	-0.05M	-418.00
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	-1.00	0.00M	1.00	1.00
Return on Assets Growth (3y) (Quarter)	0.00M	0.00M	-1.00	-1.00	-1.00	-1.00	-1.00	0.00M	0.00M	0.00M	0.00M	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)	0.00M	0.00M	0.00M	0.00M	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-2.00	-1.00	-1.00	-1.00	0.00M	0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	0.00M
Return on Capital Employed Growth (1y) (Quarter)	992.00	120.00	-112.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-500.00	692.00	0.00M	-84.00	499.00	-188.00	-977.00	-798.00	-0.00M	-0.00M	-105.00	-20.00
Return on Capital Employed Growth (3y) (Quarter)	0.01M	0.00M	0.00M	892.00	510.00	-795.00	-0.00M	-242.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-655.00	24.00	-901.00
Return on Capital Employed Growth (5y) (Quarter)	0.01M	0.01M	0.00M	0.00M	0.00M	0.00M	378.00	0.00M	0.00M	901.00	-375.00	-410.00	509.00	-291.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Capital Employed (QoQ) (Quarter)	184.00	-287.00	-496.00	-531.00	-779.00	-848.00	-380.00	789.00	-60.00	343.00	35.00	-402.00	524.00	-344.00	-754.00	-223.00	-276.00	94.00	299.00	-137.00
Return on Sales Growth (1y) (Quarter)	31.00	13.00	-6.00	7.00	-5.00	7.00	9.00	3.00	-116.00	-99.00	-211.00	-53.00	102.00	45.00	-6.00	-49.00	5.00	22.00	202.00	-11.00
Return on Sales Growth (3y) (Quarter)	10.00	-1.00	-8.00	3.00	-6.00	1.00	2.00	90.00	-90.00	-80.00	-208.00	-43.00	-19.00	-48.00	-208.00	-98.00	-9.00	-33.00	-16.00	-112.00
Return on Sales Growth (5y) (Quarter)	-1.00	-8.00	-10.00	5.00	-5.00	0.00M	5.00	12.00	-112.00	-93.00	-210.00	-47.00	-21.00	-54.00	-216.00	-12.00	17.00	-13.00	-13.00	-102.00
Return on Sales (QoQ) (Quarter)	2.00	-8.00	0.00M	12.00	-10.00	4.00	2.00	7.00	-129.00	21.00	-110.00	165.00	25.00	-36.00	-161.00	123.00	79.00	-20.00	20.00	-90.00

Research Tools

Developers

Fate Therapeutics Growth Metrics (2012-2026) | FATE

Research Tools

Developers

Fate Therapeutics Growth Metrics (2012-2026) | FATE

Create an account

Sign In

Reset Password